ImmunoGen (IMGN) Reports Wider-than-Expected Loss

ImmunoGen (IMGN) Reports Wider-than-Expected Loss

ImmunoGen, Inc. (IMGN – Analyst Report) is a clinical-stage biotechnology company, which focuses on developing targeted anticancer therapeutics using its antibody-drug conjugate (ADC) technology. This Waltham, MA-based company has several …

(Visited 1 times, 1 visits today)
4
Like
Save

Comments

Comments are disabled for this post.